Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
ALIDABRAFENIB
Rx
Cancer & Blood Disorders

ALIDABRAFENIB

Dabrafenib
Generic (INN)
Dabrafenib
Strength
75mg
Packaging
120 capsules/bottle
Indication
Targeted treatment for BRAF-mutated melanoma and other BRAF-mutated cancers. (See package insert.)
Registration No.
10 L 1222/24
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
ALIENCOFENIZ
ALIENCOFENIZ
Encorafenib
MITOSIS
MITOSIS
Mitotane
ARIMIDEX
ARIMIDEX
Anastrozole
ALIREPOTINIB
ALIREPOTINIB
Repotrectinib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文